Cepheid Overview

  • Founded
  • 1996
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $3.3M
Latest Deal Amount
  • Investors
  • 2

Cepheid General Information

Description

Developer and manufacturer of molecular systems and tests intended to optimize fast treatment decisions. The company's technology offers on-demand genetic, sexual health, and critical infectious diseases testing to provide test results which eliminate the need to perform culture confirmation of negative results.

Contact Information

Website
www.cepheid.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Parent Company
Danaher
Primary Office
  • 904 Caribbean Drive
  • Sunnyvale, CA 94089
  • United States
+1 (408) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cepheid Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 13-Nov-2014 $3.3M Completed Generating Revenue/Not Profitable
5. Merger/Acquisition 04-Nov-2016 000 000.00 000 Completed Generating Revenue/Not Profitable
4. IPO 21-Jun-2000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 06-Mar-2000 000.00 000.00 Completed Generating Revenue
2. Corporate 30-Nov-1998 $8.2M Completed Generating Revenue
1. Early Stage VC (Series B) 01-Apr-1998 $8.2M $8.2M Completed Generating Revenue
To view Cepheid’s complete valuation and funding history, request access »

Cepheid Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer and manufacturer of molecular systems and tests intended to optimize fast treatment decisions. The company's t
Diagnostic Equipment
Sunnyvale, CA
9 As of 2016
000.00
0000000000

0000000

quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
0000000000 000000000
Brea, CA
00000 As of 0000
0.000 0000-00-00
000000&0

00000000

t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000000000 000000000
Seoul, South Korea
00 As of 0000
000.00
0000 0000-00-00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cepheid Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Beckman Coulter Corporate Backed or Acquired Brea, CA 00000 000000&0
000000000000 Formerly VC-backed Seoul, South Korea 00 000.00 00000000 000.00
000000000 0000 000 Corporation Richmond Hill, Canada 00 0000 00000000 0000
00000000000 Venture Capital-Backed Birmingham, AL 00 00.000 0000000000 0 00.000
0000000 Corporate Backed or Acquired San Marcos, CA 00 000000&0
You’re viewing 5 of 14 competitors. Get the full list »

Cepheid Executive Team (14)

Name Title Board Seat Contact Info
John Bishop Chairman & Chief Executive Officer
Warren Kocmond President & Chief Operating Officer
Kerry Flom Ph.D Executive Vice President & Chief Regulatory Officer
Scott Campbell Ph.D Chief Regulatory Officer, Vice President of Clinical Affairs & Corporate Vice President
Larry Kelmar Executive Director, Corporate Development
You’re viewing 5 of 14 executive team members. Get the full list »

Cepheid Board Members (9)

Name Representing Role Since
David Persing Ph.D Cepheid Executive Vice President, Chief Medical and Technology Officer & Board Member 000 0000
Hollings Renton Self Board Member 000 0000
John Bishop Cepheid Chairman & Chief Executive Officer 000 0000
Thomas Gutshall Cepheid Co-Founder & Chairman 000 0000
You’re viewing 4 of 9 board members. Get the full list »

Cepheid Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cepheid Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advanced Technology Ventures Venture Capital Minority 000 0000 000000 0
Band of Angels Angel Group Minority 000 0000 000000 0
CampVentures Venture Capital Minority 000 0000 000000 0
Innogenetics Corporation Minority 000 0000 000000 0
Invemed Associates Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Cepheid Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 000000 01-Oct-2014 000000000 00000 00 0000 Buildings and Property 0000 000000
00000000 000000000 03-Nov-2008 000000000000000000 00.000 Diagnostic Equipment
Actigenics 09-Aug-2006 Merger/Acquisition 00.000 Biotechnology
To view Cepheid’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Cepheid Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000000 Diagnostic Equipment Stretton, United Kingdom 0000
To view Cepheid’s complete subsidiaries history, request access »